Both in Medical Labs
Caris Life Sciences vs Veracyte
Over the past year CAI returned +9.8% and VCYT returned +42.3%; their daily moves had a correlation of 0.33.
CAI +9.8% VCYT +42.3%Growth of $1, one year, split-adjusted
| Metric | CAI | VCYT |
|---|---|---|
| Price | $32.88 | $51.86 |
| Market cap | $9.29B | $4.17B |
| Today | +0.08% | +3.11% |
| 1 month | +19.7% | +16.1% |
| 6 months | +71.9% | +25.9% |
| Year to date | +21.8% | +23.2% |
| 1 year | +9.8% | +42.3% |
| Revenue growth (YoY) | +45.4% | +15.5% |
| Gross margin | 68.1% | 72.2% |
| Net margin | −0.2% | 17.0% |
| P/E (TTM) | 88.4× | 36.4× |
| Price / sales | 9.4× | 7.4× |
| Net cash | $400.0M | $485.2M |
| Dividend yield | — | — |
| Volatility (60d) | 64.7% | 54.3% |
| Short % of float | 12.5% | 12.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).